Pricing Log in Create free account

Quince Therapeutics, Inc. (IRLA) vs Metagenomi Therapeutics, Inc. (MGX)

Quince Therapeutics, Inc. and Metagenomi Therapeutics, Inc. are both Biotechnology companies. Quince Therapeutics, Inc. and Metagenomi Therapeutics, Inc. are of similar size ($33.8M and $31.9M). Quince Therapeutics, Inc. has the higher net margin (0.00% vs −689.2%) and the higher return on invested capital (0.00% vs 0.00%). Across the 11 metrics below, Quince Therapeutics, Inc. leads on 7 and Metagenomi Therapeutics, Inc. on 4.

Valuation

Metric IRLA MGX Biotechnology median
P/E n/m n/m 8.50
P/S n/m 2.17 9.71
P/B n/m 0.26 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m 0.63 0.64
EV/Sales n/m (4.50) 9.21
Earnings yield (442.37%) (319.23%) (33.15%)
Free cash flow yield (23.96%) (292.09%) (25.50%)

Profitability

Metric IRLA MGX Biotechnology median
Gross margin 0.00% 100.00% 65.16%
Operating margin 0.00% (741.58%) 0.00%
Net margin 0.00% (689.20%) 0.00%
Free cash flow margin 0.00% (632.67%) 0.00%
Return on equity 784.09% (60.61%) (56.36%)
Return on assets (76.68%) (41.91%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric IRLA MGX Biotechnology median
Revenue growth (TTM) — (59.84%) 6.02%
EPS growth (last fiscal year) (28.24%) 0.00% 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric IRLA MGX Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 14.52 4.50 4.72
Net debt to EBITDA 0.00 1.71 0.96

Dividend

Metric IRLA MGX Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric IRLA MGX Biotechnology median
Market cap 33.79m 31.93m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack